(Q57424293)
Statements
Docetaxel, vinorelbine, and zoledronic acid as first-line treatment in patients with hormone refractory prostate cancer: a phase II study (English)
Ciro Imbimbo
Riccardo Autorino
Sabino De Placido
Giuseppe Di Lorenzo
Sisto Perdonà
Massimo D'Armiento
Giuseppe Cancello
Vincenzo Altieri
William D Figg